Benzinga | Dec 10, 2021 07:05AM EST

Credit Suisse Maintains Outperform on CVS Health, Raises Price Target to $120

Credit Suisse analyst Jonathan Yong maintains CVS Health (NYSE:CVS) with a Outperform and raises the price target from $107 to $120.